36 /100
MEDIUM RISK
Score updated Jun 11, 2026

ARCT — Arcturus Therapeutics Holdings Inc. Dilution Risk Tracker

Track ARCT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ARCT — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ARCT.
🔔 Track ARCT — Get forecast alerts →

💹 Market Data

Market Cap$225.11M
Shares Outstanding28.42M
Float26.15M
Cash$211.38M
Debt$75.66M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 14.4% shares (2026Q1 vs prior)
127 institutional holders · 28.54M shares
#1 FEDERATED HERMES, INC. 3.30M shares
#2 ARK Investment Management LLC 2.77M shares
#3 BlackRock, Inc. 2.61M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest6.57M
Days to Cover13.3
% of Float25.1%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news
Track ARCT Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ARCT — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

🔬 More Research for ARCT
📊 ARCT FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ARCT Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.